Advanced Filters
noise
Found 64,783 clinical trials
F Francesco De Cobelli, MD

Liver Embolization Approaches for Tumor Management

The goal of this evaluate short, medium and long term outcome of the different embolization techniques in patients with primary and secondary hepatic tumors. The main aim is to evaluate progression free survival following embolization in this study population or evaluate residual hepatic volume in cases in which these techniques …

18 years of age All Phase N/A
A Anissa Megzari

Serum Neurofilament-light Chain and GFAP Levels in Patients From the OFSEP Cohort at Different Landmarks of Multiple Sclerosis

The investigators hypothesize that serum neurofilament-light chain (NfL) levels can provide information about the level of activity and progression of Multiple Sclerosis at different stages and landmarks of the disease. In addition, Glial Fibrillary Acidic Protein (GFAP) has also been identified as another serum biomarker of disability in MS.

15 years of age All Phase N/A
H Hui-Nam Pak, M.D., Ph.D.

The Evaluation for Prognostic Factors After Catheter Ablation of Atrial Fibrillation: Cohort Study

Purpose of the study To explore clinical recurrence associated clinical factors including age, sex, clinical, electrophysiological, anatomical, imaging, and serologic characteristics. To develop simulation model to predict clinical recurrence and the efficacy of catheter ablation 2. Scientific evidence of the study In atrial fibrillation patients, the maintenance of normal sinus …

19 years of age All Phase N/A
B Benedikt Koell, MD

Outcomes of Patients tReated wIth Mitral Transcatheter Edge-to-edge Repair for Primary Mitral Regurgitation Registry

This multinational, non-interventional, investigator-initiated, retrospective study aims to investigate outcomes of patients, who underwent mitral valve transcatheter edge-to-edge repair (M-TEER) for primary mitral regurgitation (PMR).

18 years of age All Phase N/A

Epidemiological and Molecular Colorectal Cancer Registry

This is a Registry that invites patients undergoing colorectal surgery for colorectal cancer. Epidemiological data is collected. The Registry includes tumor tissue and blood banks for analyzing different genetic mutations and disease-specific biomarkers.

21 - 96 years of age All Phase N/A
D Dachun Xu, MD,PhD

Registry for Longitudinal Mortality and Therapy in Patients With Heart Failure

The purpose of this registry is to compile a large clinical database on the medical management of patients hospitalized with acute heart failure, using information collected from hospitals across China.

18 - 90 years of age All Phase N/A

Neurofibromatosis (NF) Registry Portal

The NF Registry is a database of patient-reported symptoms, treatments, and experiences with their neurofibromatosis disease. It is a contact registry to relay clinical trial opportunities to targeted patient subgroups, and to supply de-identified disease data to researchers. It has the potential to become a natural history resource.

years of age All Phase N/A
G Guang Ning, MD,PHD

Genetics of Obesity in Chinese Youngs

The purpose of this study is to explore the pathogenesis and genetic susceptibility of obese subjects,providing a convincing argument for further treatment of obesity and metabolic syndrome.

14 - 30 years of age All Phase N/A
A Adnan Abaci

Turkish Isolated Coronary Ectasia Registry: The T-ICE Registry

The T-ICE study is a prospective, observational study aiming to have information about the treatment and long-term prognosis of patients with isolated coronary artery ectasia.

18 - 90 years of age All Phase N/A
P Peter Bondeven, MD, PhD

DANISH.MRD: Danish Assessment of Minimal Residual Disease by Liquid Biopsies

Approximately two-thirds of all colorectal cancer patients undergo surgery with the aim of curing them. However, despite the surgery, 20-25% of them experience relapse. It is possible to reduce the risk of relapse with chemotherapy, but as chemotherapy is associated with significant side effects, it is only given to patients …

18 years of age All Phase N/A

Simplify language using AI